Moderna’s shrinking revenue, expected losses, and weak financial score make it a stock to sell. Looking for more actionable trade ideas? Subscribe here to unlock access to ProPicks AI winners.

Moderna’s shrinking revenue, expected losses, and weak financial score make it a stock to sell ... plummet almost 70% year-over-year to $951.1 million. The biotech company is now facing ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made ...

If that pattern continues, the stock's current valuation may look more reasonable in hindsight. But investors should be careful chasing this stock at its current price. A more prudent course of ...

Six months ago, the four largest pure play stocks in this market added up to a total market value of $1.9 billion ... and those beefy stock valuations appear to be based on unrealistic assumptions ...

But I view the current situation as being way too expensive. As of this writing, the stock trades at a price-to-earnings (P/E) ratio of 50. That's a ridiculously high valuation that you're being ...

Jumping to conclusions may be great exercise, but it can be dangerous to your stock portfolio. Meanwhile, the Google Quantum AI team keeps doing their research. The error-correction function was ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

IOL Chemicals and Pharmaceuticals Limited (IOLCP), a prominent pharmaceutical (API) company and a major participant in the speciality chemicals market with top-notch facilities was founded in 1986 ...

After hours: 7:59:56 pm GMT-5 ...